Suchergebnisse - "Cao, Bin"

PubPharm (19)

1

Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China

enthalten in: Influenza and other respiratory viruses | 2020

von Zhang, Y. | Wang, Y. | Zhao, J. | +10

2

Comparison of severity scores for COVID-19 patients with pneumonia : a retrospective study

enthalten in: The European respiratory journal | 2020

von Fan, G. | Tu, C. | Zhou, F. | +13

3

Comparative transcriptomics of Gymnosporangium spp. teliospores reveals a conserved genetic program at this specific stage of the rust fungal life cycle

enthalten in: BMC genomics | 2019

von Tao, S. | Cao, B. | Morin, E. | +2

4

Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2019

von Zou, X. | Chang, K. | Wang, Y. | +10

5

Differences in inflammatory marker patterns for adult community-acquired pneumonia patients induced by different pathogens

enthalten in: The clinical respiratory journal | 2018

von Liu, M. | Li, H. | Xue, C. | +6

6

Evaluating the utility of Binax NOW Streptococcus pneumoniae urinary antigen test in adults with community acquired pneumonia in China

enthalten in: The clinical respiratory journal | 2018

von Zhou, F. | Gu, L. | Qu, J. | +3

7

Comparative transcriptome analysis and identification of candidate effectors in two related rust species (Gymnosporangium yamadae and Gymnosporangium asiaticum)

enthalten in: BMC genomics | 2017

von Tao, S. | Cao, B. | Tian, C. | +1

8

Mortality prediction to hospitalized patients with influenza pneumonia : PO2 /FiO2 combined lymphocyte count is the answer

enthalten in: The clinical respiratory journal | 2017

von Shi, S. | Li, H. | Liu, M. | +5

9

Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day) : prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial

enthalten in: International urology and nephrology | 2017

von Ren, H. | Li, X. | Ni, Z. | +15

10

In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China

enthalten in: Journal of medical microbiology | 2016

von Li, S. | Guo, Y. | Zhao, C. | +27